31.31

3.95% 1.19

After Hours: 31.31

Vtv Therapeutics Inc (VTVT)

Overview News Price History Financials Discussions Forecast

Vtv Therapeutics Inc stock is traded at $31.31, with a volume of 38,770. It is up +3.95% in the last 24 hours and down -4.77% over the past month. vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Previous Close:

$30.12

Open:

$29.93

24h Volume:

38,770

Relative Volume:

0.54

Market Cap:

$123.80M

Revenue:

$36.84M

Net Income/Loss:

$-729.00K

P/E Ratio:

-33.90

EPS:

-0.9237

Net Cash Flow:

$-10.02M

1W Performance:

-8.69%

1M Performance:

-4.77%

6M Performance:

-15.20%

1Y Performance:

+102.78%

1-Day Range:

$29.48

$31.42

1-Week Range:

$28.76

$36.52

52-Week Range:

$14.55

$44.00

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name

Vtv Therapeutics Inc

Sector

Healthcare (1082)

Industry

Biotechnology (606)

Phone

336-841-0300

Address

3980 PREMIER DR, HIGH POINT, NC

Employee

Twitter

@vTvTherapeutics

Next Earnings Date

2026-08-11

Latest SEC Filings

VTVT's Discussions on Twitter

Compare VTVT vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VTVT Vtv Therapeutics Inc	31.31	119.09M	36.84M	-729.00K	-10.02M	-0.9237
VRTX Vertex Pharmaceuticals Inc	515.55	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	805.93	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	987.84	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	212.00	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.51	39.31B	5.76B	514.49M	1.10B	4.4813

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Initiated	Evercore ISI	Outperform
Jan-23-26	Initiated	Roth Capital	Buy
Jan-05-26	Initiated	TD Cowen	Buy
Nov-19-25	Initiated	BTIG Research	Buy
May-30-19	Initiated	H.C. Wainwright	Buy
Apr-10-18	Downgrade	Stifel	Buy → Hold
Mar-08-18	Initiated	ROTH Capital	Buy
Feb-08-18	Initiated	Northland Capital	Outperform
Sep-26-16	Initiated	H.C. Wainwright	Buy
Sep-04-15	Initiated	Canaccord Genuity	Buy
Aug-24-15	Initiated	Piper Jaffray	Overweight
Aug-24-15	Initiated	Stifel	Buy

View All

Vtv Therapeutics Inc Stock (VTVT) Latest News

Aug 14, 2026

The Technical Signals Behind (VTVT) That Institutions Follow - Stock Traders Daily

Aug 14, 2026

Aug 10, 2026

vTv Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 10, 2026

HC Wainwright Lowers Earnings Estimates for vTv Therapeutics - MarketBeat

Aug 10, 2026

Aug 09, 2026